Effective antiviral treatment of systemic orthopoxvirus disease: ST-246 treatment of prairie dogs infected with monkeypox virus.
about
The effects of post-exposure smallpox vaccination on clinical disease presentation: addressing the data gaps between historical epidemiology and modern surrogate model dataTransmissibility of the monkeypox virus clades via respiratory transmission: investigation using the prairie dog-monkeypox virus challenge systemThe pox in the North American backyard: Volepox virus pathogenesis in California mice (Peromyscus californicus).A cutting-edge view on the current state of antiviral drug development.Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone.Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection.Comparison of Monkeypox Virus Clade Kinetics and Pathology within the Prairie Dog Animal Model Using a Serial Sacrifice Study DesignPharmacokinetic and pharmacodynamic modeling to determine the dose of ST-246 to protect against smallpox in humans.Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox - an animal model of smallpoxOrthopoxvirus inhibitors that are active in animal models: an update from 2008 to 2012.Monkeypox virus infections in small animal models for evaluation of anti-poxvirus agents.A review of experimental and natural infections of animals with monkeypox virus between 1958 and 2012.Buccal viral DNA as a trigger for brincidofovir therapy in the mousepox model of smallpox.ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrapping.Evaluation of Taterapox Virus in Small Animals.Using the Ground Squirrel (Marmota bobak) as an Animal Model to Assess Monkeypox Drug Efficacy.Are We Prepared in Case of a Possible Smallpox-Like Disease Emergence?Challenges and Achievements in Prevention and Treatment of Smallpox.
P2860
Q26996686-D8958F81-DE7F-4429-A224-EDD1B1CA1975Q28394190-F0D420F0-234E-4905-AFC0-9C88543265A2Q31089185-EFEBC5CC-FF30-4582-9F63-59E9827F618EQ34036018-08893DE5-CD3C-4A53-B64C-9DB2F4A2D40AQ35738585-5F05B08C-4766-4EC7-92D5-2669F1B7AE70Q35745996-FB9BE5D9-3D9E-46B0-946D-F12E12FC5FE6Q36032004-CC361D9B-EFC9-4D34-8D9D-0D59B2592A79Q36667010-470110F6-40C0-4009-A095-516F01FE0CFBQ37043625-6487DA8B-F373-45C1-A764-F33EA9AD3E80Q37593480-1EB2813B-75EB-4104-86F1-2272F91C25D3Q37945197-74863132-8337-473E-9EE5-7938A859A7FDQ38102696-B3765A7D-2189-4451-AA25-FE13DBFC9B3CQ38957078-4EBF8BAD-3C8B-4F9D-89A4-06A55605E0FCQ39046951-D244232E-71CE-452C-8C92-7E50879BF3F2Q40099794-759E756E-0374-4964-8FDD-19823677DAB0Q41257119-A51A038E-3F98-4AC3-82E1-1587B1036C4FQ47116100-AA1885ED-000D-436D-8FB9-E4FB504C2952Q47547852-894E8939-49D6-4375-BE76-4C72426A7885
P2860
Effective antiviral treatment of systemic orthopoxvirus disease: ST-246 treatment of prairie dogs infected with monkeypox virus.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Effective antiviral treatment ...... infected with monkeypox virus.
@ast
Effective antiviral treatment ...... infected with monkeypox virus.
@en
type
label
Effective antiviral treatment ...... infected with monkeypox virus.
@ast
Effective antiviral treatment ...... infected with monkeypox virus.
@en
prefLabel
Effective antiviral treatment ...... infected with monkeypox virus.
@ast
Effective antiviral treatment ...... infected with monkeypox virus.
@en
P2093
P2860
P356
P1433
P1476
Effective antiviral treatment ...... infected with monkeypox virus.
@en
P2093
Darin Carroll
Dennis E Hruby
Inger K Damon
Russell L Regnery
Scott K Smith
Sonja Weiss
Whitni Davidson
Zach Braden
P2860
P304
P356
10.1128/JVI.02173-10
P577
2011-06-22T00:00:00Z